Sandra S. Hammer

640 total citations
18 papers, 474 citations indexed

About

Sandra S. Hammer is a scholar working on Surgery, Molecular Biology and Ophthalmology. According to data from OpenAlex, Sandra S. Hammer has authored 18 papers receiving a total of 474 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 9 papers in Molecular Biology and 6 papers in Ophthalmology. Recurrent topics in Sandra S. Hammer's work include Cholesterol and Lipid Metabolism (8 papers), Retinal Diseases and Treatments (5 papers) and Peroxisome Proliferator-Activated Receptors (3 papers). Sandra S. Hammer is often cited by papers focused on Cholesterol and Lipid Metabolism (8 papers), Retinal Diseases and Treatments (5 papers) and Peroxisome Proliferator-Activated Receptors (3 papers). Sandra S. Hammer collaborates with scholars based in United States and Spain. Sandra S. Hammer's co-authors include Julia V. Busik, Chao Huang, Svetlana Navitskaya, G. J. Blanchard, Gary W. McCollum, John S. Penn, Megan E. Capozzi, Todd A. Lydic, Maria B. Grant and Dibyendu Chakraborty and has published in prestigious journals such as Diabetes, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Sandra S. Hammer

18 papers receiving 470 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sandra S. Hammer United States 11 246 181 69 67 59 18 474
Sang Yeop Kim United States 9 301 1.2× 130 0.7× 32 0.5× 220 3.3× 40 0.7× 19 622
Sophia I. Pachydaki United States 9 273 1.1× 286 1.6× 32 0.5× 56 0.8× 112 1.9× 17 700
Antonela Gverović Antunica Croatia 12 114 0.5× 367 2.0× 18 0.3× 68 1.0× 158 2.7× 22 561
D. B. Archer United Kingdom 10 156 0.6× 177 1.0× 40 0.6× 39 0.6× 73 1.2× 22 511
Anna Bryl Poland 11 121 0.5× 181 1.0× 21 0.3× 24 0.4× 98 1.7× 24 433
Khaled Elmasry Egypt 11 133 0.5× 120 0.7× 17 0.2× 41 0.6× 44 0.7× 21 357
Shingo Nemoto Japan 10 179 0.7× 194 1.1× 19 0.3× 17 0.3× 100 1.7× 21 475
Jing Meng China 13 116 0.5× 33 0.2× 36 0.5× 59 0.9× 57 1.0× 35 547

Countries citing papers authored by Sandra S. Hammer

Since Specialization
Citations

This map shows the geographic impact of Sandra S. Hammer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra S. Hammer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra S. Hammer more than expected).

Fields of papers citing papers by Sandra S. Hammer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra S. Hammer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra S. Hammer. The network helps show where Sandra S. Hammer may publish in the future.

Co-authorship network of co-authors of Sandra S. Hammer

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra S. Hammer. A scholar is included among the top collaborators of Sandra S. Hammer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra S. Hammer. Sandra S. Hammer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Hammer, Sandra S., Natalia Mast, Seth D. Fortmann, et al.. (2023). Cholesterol crystal formation is a unifying pathogenic mechanism in the development of diabetic retinopathy. Diabetologia. 66(9). 1705–1718. 9 indexed citations
2.
Mast, Natalia, et al.. (2022). 2-Hydroxypropyl-β-cyclodextrin mitigates pathological changes in a mouse model of retinal cholesterol dyshomeostasis. Journal of Lipid Research. 64(2). 100323–100323. 3 indexed citations
3.
Vieira, Cristiano Pedrozo, et al.. (2021). Intravitreal AAV2-SIRT1 administration reverses diabetic retinopathy in db/db mice. Investigative Ophthalmology & Visual Science. 62(8). 1106–1106. 2 indexed citations
4.
Hammer, Sandra S., Cristiano Pedrozo Vieira, Todd A. Lydic, et al.. (2021). Fasting and fasting-mimicking treatment activate SIRT1/LXRα and alleviate diabetes-induced systemic and microvascular dysfunction. Diabetologia. 64(7). 1674–1689. 61 indexed citations
5.
Hammer, Sandra S., et al.. (2020). Cholesterol crystals promote diabetic retinopathy (DR) pathology.. Investigative Ophthalmology & Visual Science. 61(7). 1 indexed citations
6.
Hammer, Sandra S., et al.. (2020). SIRT1 Activation and mitochondrial dynamics in Retinal Endothelial Cells.. Investigative Ophthalmology & Visual Science. 61(7). 729–729. 1 indexed citations
7.
Vieira, Cristiano Pedrozo, Seth D. Fortmann, Ana Leda F. Longhini, et al.. (2020). Selective LXR agonist DMHCA corrects retinal and bone marrow dysfunction in type 2 diabetes. JCI Insight. 5(13). 11 indexed citations
8.
Huang, Chao, et al.. (2020). Extracellular Vesicle-Induced Classical Complement Activation Leads to Retinal Endothelial Cell Damage via MAC Deposition. International Journal of Molecular Sciences. 21(5). 1693–1693. 24 indexed citations
9.
Hammer, Sandra S., et al.. (2020). Mitochondrial Ceramide Effects on the Retinal Pigment Epithelium in Diabetes. International Journal of Molecular Sciences. 21(11). 3830–3830. 13 indexed citations
10.
Hammer, Sandra S., et al.. (2019). Ceramide-Induced Mitochondrial Changes in Retinal Endothelial Cells. Investigative Ophthalmology & Visual Science. 60(9). 2707–2707. 1 indexed citations
11.
Capozzi, Megan E., Sara R. Savage, Gary W. McCollum, et al.. (2019). The peroxisome proliferator-activated receptor-β/δ antagonist GSK0660 mitigates retinal cell inflammation and leukostasis. Experimental Eye Research. 190. 107885–107885. 16 indexed citations
12.
Hammer, Sandra S., et al.. (2019). Micro-respirometry of whole cells and isolated mitochondria. RSC Advances. 9(57). 33257–33267. 8 indexed citations
13.
Liu, Xuwen, Todd A. Lydic, Svetlana Navitskaya, et al.. (2018). ELOVL4-Mediated Production of Very Long-Chain Ceramides Stabilizes Tight Junctions and Prevents Diabetes-Induced Retinal Vascular Permeability. Diabetes. 67(4). 769–781. 41 indexed citations
14.
Saadane, Aicha, Natalia Mast, George Trichonas, et al.. (2018). Retinal Vascular Abnormalities and Microglia Activation in Mice with Deficiency in Cytochrome P450 46A1–Mediated Cholesterol Removal. American Journal Of Pathology. 189(2). 405–425. 31 indexed citations
15.
Huang, Chao, et al.. (2018). Plasma Exosomes Contribute to Microvascular Damage in Diabetic Retinopathy by Activating the Classical Complement Pathway. Diabetes. 67(8). 1639–1649. 100 indexed citations
16.
Hammer, Sandra S. & Julia V. Busik. (2017). The role of dyslipidemia in diabetic retinopathy. Vision Research. 139. 228–236. 65 indexed citations
17.
Hammer, Sandra S., Eleni Beli, Qi Wang, et al.. (2017). The Mechanism of Diabetic Retinopathy Pathogenesis Unifying Key Lipid Regulators, Sirtuin 1 and Liver X Receptor. EBioMedicine. 22. 181–190. 47 indexed citations
18.
Capozzi, Megan E., Sandra S. Hammer, Gary W. McCollum, & John S. Penn. (2016). Epoxygenated Fatty Acids Inhibit Retinal Vascular Inflammation. Scientific Reports. 6(1). 39211–39211. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026